Antiphospholipid antibody syndrome (APS) may lead to pulmonary hypertension, a lethal complication of chronic pulmonary thromboembolism. There are few viable treatment options for pulmonary ...

Management of chronic thromboembolic pulmonary hypertension (CTEPH) includes multimodal therapy that depends on expert centres' experience.1,2 Guidelines advocate for pulmonary endarterectomy (PEA) to ...

Today we're talking about chronic thromboembolic pulmonary hypertension (PH). I'm Vallerie McLaughlin, professor of medicine at the University of Michigan.

Chronic thromboembolic pulmonary hypertension (CTEPH) is high blood pressure in the arteries in your lungs. You can get it after you've had a pulmonary embolism (PE) -- a blood clot in your lung.

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare form of pulmonary hypertension. This is caused by a pro-inflammatory state secondary to unresolved clot that results in pulmonary vessel ...

Recurrent pulmonary embolism as a cause of chronic heart disease was probably first recognized by Ljungdahl 8 in 1928. Brenner, 9 in his systematic studies of the pulmonary vasculature in 1935 ...

In the patients with pulmonary thromboembolism the major arteriographic abnormalities were complete or incomplete obstruction of various pulmonary arterial branches (Fig. 3 B, 4 B and 5 B ...

Ten more were diagnosed with isolated deep vein thrombosis (DVT), making the prevalence of venous thromboembolism (VTE) 7.3% (95% CI 5.6% to 9.4%) at admission.

Emphysema and chronic bronchitis are both respiratory conditions that fall under the classification of chronic obstructive pulmonary disease, or COPD. The symptoms may overlap. Learn more here.

The phosphodiesterase-5 (PDE-5) inhibitor, sildenafil, has been reported to produce sustained pulmonary vasodilatation in patients with pulmonary hypertension (PH). Recently, vardenafil, a more ...

The research found the rate of chronic pulmonary illnesses among current vapers is 1.3 times higher than for non-users, compared to 2.6 times higher for smokers and more than three times as high ...

Crown Princess Mette-Marit of Norway will be shifting her royal responsibilities as her chronic pulmonary fibrosis has "progressed," the Royal House of Norway announced on March 6.